Search hospitals > Virginia > Richmond
Novartis Investigative Site
Claim this profileRichmond, Virginia 23226
Global Leader in Chronic Obstructive Pulmonary Disease
Global Leader in Coronavirus
Conducts research for Atopic Dermatitis
Conducts research for Flu
Conducts research for Heart Failure
145 reported clinical trials
6 medical researchers
Summary
Novartis Investigative Site is a medical facility located in Richmond, Virginia. This center is recognized for care of Chronic Obstructive Pulmonary Disease, Coronavirus, Atopic Dermatitis, Flu, Heart Failure and other specialties. Novartis Investigative Site is involved with conducting 145 clinical trials across 137 conditions. There are 6 research doctors associated with this hospital, such as Omer Khalid, Kara Foster-Weiss, Call, Robert, and Leroy Vaughan.Top PIs
Omer KhalidGI Select Health Research, LLC6 years of reported clinical research
Studies Nonalcoholic Steatohepatitis
Studies Non-alcoholic Fatty Liver Disease
3 reported clinical trials
5 drugs studied
Kara Foster-WeissClinical Research Partners, LLC6 years of reported clinical research
Studies Crohn's Disease
2 reported clinical trials
1 drug studied
Call, RobertClinical Research Partners, LLC3 years of reported clinical research
Studies Celiac Disease
1 reported clinical trial
1 drug studied
Leroy VaughanClinical Research Partners2 years of reported clinical research
Studies Coronavirus
1 reported clinical trial
3 drugs studied
Clinical Trials running at Novartis Investigative Site
Celiac Disease
Flu
Obesity
Lyme Disease
Type 2 Diabetes
Attention-Deficit/Hyperactivity Disorder (ADHD)
Attention Deficit Hyperactivity Disorder (ADHD)
Lyme Neuroborreliosis
Respiratory Syncytial Virus Infection
Respiratory Syncytial Virus
Amlitelimab
for Celiac Disease
This is a Phase 2a/b, randomized, double-blind, placebo-controlled, parallel-group, 6-arm study to evaluate the efficacy and safety of amlitelimab in adult participants with non-responsive celiac disease (NRCD) who are on a gluten free diet (GFD) with and without simulated inadvertent gluten exposure (SIGE). The primary purpose of this study is to demonstrate the efficacy of subcutaneous (SC) amlitelimab in male and female participants (aged 18 to 75 years, inclusive) with NRCD. The study will assess the effect of amlitelimab when compared to placebo on gluten induced changes in the intestinal mucosa as measured by the villous height to crypt depth (Vh:Cd) ratio. The effect of amlitelimab on participant-reported celiac signs and symptoms along with the safety, tolerability, and pharmacokinetics of amlitelimab will also be studied. Study details include: The study duration will be up to 48 weeks (including a 16-week safety follow-up period) with 10 visits for participants who opt not to enter the optional long-term extension. The study duration will be up to 172 weeks (including an 8-week safety follow-up period) with 22 visits for participants who enter the optional long-term extension. The double-blind placebo-controlled treatment duration will be up to 28 weeks.
Recruiting0 awards Phase 24 criteria
VTP-1000
for Celiac Disease
GLU001 is a first-in-human clinical trial to assess the safety and tolerability of VTP-1000 for adults with celiac disease. This trial will assess VTP-1000 at various dose levels compared to placebo in a single ascending dose (SAD) and multiple ascending dose (MAD) format. Participants will be followed for a short period of time to assess the impact of VTP-1000 on their immune system (Adverse events, reactions in the blood, and physical exam differences). Participants enrolled in the MAD portion of the trial will undergo a gluten challenge to assess the impact exposure to gluten has on participants after administration of VTP-1000.
Recruiting0 awards Phase < 13 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Novartis Investigative Site?
Novartis Investigative Site is a medical facility located in Richmond, Virginia. This center is recognized for care of Chronic Obstructive Pulmonary Disease, Coronavirus, Atopic Dermatitis, Flu, Heart Failure and other specialties. Novartis Investigative Site is involved with conducting 145 clinical trials across 137 conditions. There are 6 research doctors associated with this hospital, such as Omer Khalid, Kara Foster-Weiss, Call, Robert, and Leroy Vaughan.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.